Cholesterol oxidation products in the vascular remodeling due to atherosclerosis

Molecular Aspects of Medicine

Volumn 30, Issue 3, 2009, Pages 180-189

  Poli, Giuseppe ^a   Sottero, Barbara ^a   Gargiulo, Simona ^a   Leonarduzzi, Gabriella ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

9 Oxononanoyl cholesterol; Atherosclerosis; Cholesterol oxidation; Inflammation; Oxysterols

Indexed keywords

CHOLESTEROL; CYTOKINE; LIPID;

APOPTOSIS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MIGRATION; DEGRADATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MALE; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; REVIEW;

ATHEROSCLEROSIS; CHOLESTEROL; HUMANS; OXIDATION-REDUCTION;

ANIMALIA;

EID: 67349248123     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2009.02.003     Document Type: Review

References (66)

1. Berthier A., Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Pais de Barros J.P., Monier S., Gambert P., Lizard G., and Néel D. 7-Ketocholesterol induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. FEBS J. 272 (2005) 3093-3104
2. Biasi F., Tessitore L., Zanetti D., Cutrin J.C., Zingaro B., Chiarpotto E., Zarkovic N., Serviddio G., and Poli G. Associated changes of lipid peroxidation and transforming growth factor β1 levels in human colon cancer during tumour progression. Gut 50 (2002) 361-367
3. Biasi F., Leonarduzzi G., Vizio B., Zanetti D., Sevanian A., Sottero B., Verde V., Zingaro B., Chiarpotto E., and Poli G. Oxysterol mixtures prevent pro-apoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. FASEB J. 18 (2004) 693-695
4. Deckert V., Perségol L., Viens L., Lizard G., Athias A., Lallemant C., Gambert P., and Lagrost L. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 95 (1997) 723-731
5. Deckert V., Brunet A., Lantoine F., Lizard G., Millanvoye-van Brussel E., Monier S., Lagrost L., David-Dufilho M., Gambert P., and Devynck M.-A. Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1054-1060
6. Erridge C., Webb D.J., and Spickett C.M. 25-Hydroxycholesterol, 7β-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic. Res. 41 (2007) 260-266
7. Frostegård J., Nilsson J., Haegerstrand A., Hamsten A., Wigzell H., and Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. USA. 87 (1990) 904-908
8. Fuhrman B., Partoush A., Volkova N., and Aviram M. Ox-LDL induces monocyte-to-macrophage differentiation in vivo: possible role for the macrophage colony stimulating factor receptor (M-CSF-R). Atherosclerosis 196 (2008) 598-607
9. Galis Z.S., Suhova G.K., Lark M.W., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94 (1994) 2493-2503
10. Gargiulo, S., Gamba, P., Sottero, B., Biasi, F., Chiarpotto, E., Serviddio, G., Vendemmiale, G., Poli, G., Leonarduzzi, G., in press. The core-aldehyde 9-oxononanoyl cholesterol stimulates expression of TGF1 specific receptors on macrophage cell membranes. Aging Cell, doi:10.1111/j.1474-9726.2009.00454.x.
11. Gordon D., Reidy M., Benditt E., and Schwartz S. Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. USA 87 (1990) 4600-4604
12. Guyton J.R., Black B.L., and Seidel C.L. Focal toxicity of oxysterols in vascular smooth muscle cell culture. Am. J. Pathol. 137 (1990) 425-434
13. Hajjar D.P., and Haberland M.E. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J. Biol. Chem. 272 (1997) 22975-22978
14. Hayden J.M., Brachova L., Higgins K., Obermiller L., Sevanian A., Khandrika S., and Reaven P.D. Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J. Lipid Res. 43 (2002) 26-35
15. Hoppe G., Ravandi A., Herrera D., Kuksis A., and Hoff H.F. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesion. J. Lipid Res. 38 (1997) 1347-1360
16. Huber J., Boechzelt H., Karten B., Surboeck M., Bochkov V.N., Binder B.R., Sattler W., and Leitinger N. Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 581-586
17. Kamido H., Kuksis A., Marai L., and Myher J.J. Identification of core-aldehydes among in vitro peroxidation products of cholesteryl esters. Lipids 28 (1993) 331-336
18. Kamido H., Kuksis A., Marai L., and Myher J.J. Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma lipoproteins. J. Lipid Res. 36 (1995) 1876-1886
19. Karten B., Boechzelt H., Abuja P.M., Mittelbach M., Oettl K., and Sattler W. Femtomole analysis of 9-oxononanoyl cholesterol by high performance liquid chromatography. J. Lipid Res. 39 (1998) 1508-1519
20. Kawai Y., Saito A., Shibata N., Kobayashi M., Yamada S., Osawa T., and Uchida K. Covalent binding of oxidized cholesteryl esters to protein. J. Biol. Chem. 278 (2003) 21040-21049
21. Kawai Y., Miyoshi M., Moon J.H., and Terao J. Detection of cholesteryl ester hydroperoxide isomers using gas chromatography-mass spectrometry combined with thin-layer chromatography blotting. Anal. Biochem. 360 (2006) 130-137
22. Leitinger N. Cholesteryl ester oxidation products in atherosclerosis. Mol. Aspects Med. 24 (2003) 239-250
23. Lemaire S., Lizard G., Monier S., Miguet C., Gueldry S., Volot F., Gambert P., and Néel D. Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-, 7β-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett. 440 (1998) 434-439
24. Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., Corcos L., Gambert P., Néel D., and Lizard G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 21 (2005) 97-114
25. Lemaire-Ewing S., Berthier A., Royer M.C., Logette E., Corcos L., Bouchot A., Monier S., Prunet C., Raveneau M., Rébé C., Desrumaux C., Lizard G., and Néel D. 7β-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent. Cell Biol. Toxicol. 25 (2009) 127-139
26. Leonarduzzi G., Scavezza A., Biasi F., Chiarpotto E., Camandola S., Vogel S., Dargel R., and Poli G. The lipid peroxidation end product 4-hydroxy-2, 3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11 (1997) 851-857
27. Leonarduzzi G., Sevanian A., Sottero B., Arkan M.C., Biasi F., Chiarpotto E., Basaga H., and Poli G. Up-regulation of the fibrogenic cytokine TGF-beta1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. FASEB J. 15 (2001) 1619-1621
28. Leonarduzzi G., Sottero B., and Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects. J. Nutr. Biochem. 13 (2002) 700-710
29. Leonarduzzi G., Chiarpotto E., Biasi F., and Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 49 (2005) 1044-1049
30. Leonarduzzi G., Gamba P., Sottero B., Kadl A., Robbesyn F., Calogero R.A., Biasi F., Chiarpotto E., Leitinger N., Sevanian A., and Poli G. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic. Biol. Med. 39 (2005) 1152-1161
31. Leonarduzzi G., Vizio B., Sottero B., Verde V., Gamba P., Mascia C., Chiarpotto E., Poli G., and Biasi F. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid. Redox Signal. 8 (2006) 375-380
32. Leonarduzzi G., Poli G., Sottero B., and Biasi F. Activation of the mitochondrial pathway of apoptosis by oxysterols. Front. Biosci. 12 (2007) 791-799
33. Leonarduzzi G., Gamba P., Gargiulo S., Sottero B., Kadl A., Biasi F., Chiarpotto E., Leitinger N., Vendemmiale G., Serviddio G., and Poli G. Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture. Aging Cell 7 (2008) 375-382
34. Liu Y., Hultén L.M., and Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 317-323
35. Lizard G., Lemaire S., Monier S., Gueldry S., Néel D., and Gambert P. Induction of apoptosis and of interleukin-1β secretion by 7β-hydroxycholesterol and 7-ketocholesterol: partial inhibition by Bcl-2 overexpression. FEBS Lett. 419 (1997) 276-280
36. Meynier A., Lherminier J., Demaison-Meloche J., Ginies C., Grandgirard A., and Demaison L. Effects of dietary oxysterols on coronary arteries in hyperlipidaemic hamsters. Brit. J. Nutr. 87 (2002) 447-458
37. Millanvoye-Van Brussel E., Topal G., Brunet A., Do Pham T., Deckert V., Rendu F., and David-Dufilho M. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. Biochem. J. 380 (2004) 533-539
38. Moreau M., Brocheriou I., Petit L., Ninio E., Chapman M.J., and Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation 99 (1999) 420-426
39. Moriel P., Sevanian A., Ajzen S., Zanella M.T., Plavnik F.L., Rubbo H., and Abdalla D.S. Nitric oxide, cholesterol oxides and endothelium-dependent vasodilation in plasma of patients with essential hypertension. Braz. J. Med. Biol. Res. 35 (2002) 1301-1309
40. Mougenot N., Lesnik P., Ramirez-Gil J.F., Nataf P., Diczfalusy U., Chapman M.J., and Lechat P. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro. Atherosclerosis 133 (1997) 183-192
41. Naito Y., Shimozawa M., Manabe H., Kuroda M., Tomatsuri N., Uchiyama K., Takagi T., Yoshida N., and Yoshikawa T. Inhibitory effects of red wine extracts on endothelial-dependent adhesive interactions with monocytes induced by oxysterols. Biol. Res. 37 (2004) 231-238
42. Newby A.C., and Saltzman A.B. Fibrous cap formation or destruction: the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 41 (1999) 345-360
43. Ohtsuka M., Miyashita Y., and Shirai K. Lipids deposited in human atheromatous lesions induce apoptosis of human vascular smooth muscle cells. J. Atheroscler. Thromb. 13 (2006) 256-262
44. Oyama T., Miyashita Y., Kinoshita K., Watanabe H., Shirai K., and Yagima T. Effect of deposited lipids in atheromatous lesions on the migration of vascular smooth muscle cells. J. Atheroscler. Thromb. 9 (2002) 109-113
45. Peng S.K., Taylor C.B., Hill J.C., and Morin R.J. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis 54 (1985) 121-133
46. Penn M.S., Cui M.-Z., Winokur A.L., Bethea J., Hamilton T.A., DiCorleto P.E., and Chisolm G.M. Smooth muscle cell surface tissue factor pathway activation by oxidized low density lipoprotein requires cellular lipid peroxidation. Blood 96 (2000) 3056-3063
47. Poli G., and Parola M. Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22 (1997) 287-305
48. Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.F., Riedinger J.M., Athias A., Lemaire-Ewing S., Néel D., Petit J.M., Steinmetz E., Brenot R., Gambert P., and Lizard G. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 69 (2006) 359-373
49. Rajavashisth T.B., Andalibi A., Territo M.C., Berliner J.A., Navab M., Fogelman A.M., and Lusis A.J. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344 (1990) 254-257
50. Ramasamy S., Boissonneault G.A., and Hennig B. Oxysterol-induced endothelial cell dysfunction in culture. J. Am. Coll. Nutr. 11 (1992) 532-538
51. Romeo G., Frangioni J.V., and Kazlauskas A. Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction. FASEB J. 18 (2004) 725-727
52. Rong J.X., Rangaswamy S., Shen L., Dave R., Chang Y.H., Peterson H., Hodis H.N., Chisolm G.M., and Sevanian A. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1885-1894
53. Rosenblat M., and Aviram M. Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160 (2002) 69-80
54. Rosklint T., Ohlsson B.G., Wilklund O., Norén K., and Hultén L.M. Oxysterols induce interleukin-1β production in human macrophages. Eur. J. Clin. Invest. 32 (2002) 35-42
55. Rydberg E.K., Salomonsson L., Hultén L.M., Norén K., Bondjers G., Wiklund O., Björnheden T., and Ohlsson B.G. Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis 170 (2003) 245-252
56. Schroepfer G.J.Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80 (2000) 361-554
57. Sevanian A., Hodis H.N., Hwang J., McLeod L.L., and Peterson H. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J. Lipid Res. 36 (1995) 1971-1986
58. Shimokawa H., and Vanhoutte P.M. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ. Res. 64 (1989) 900-914
59. Shimozawa M., Naito Y., Manabe H., Uchiyama K., Kuroda M., Katada K., Yoshida N., and Yoshikawa T. 7-Ketocholesterol enhances the expression of adhesion molecules on human aortic endothelial cells by increasing the production of reactive oxygen species. Redox Rep. 9 (2004) 370-375
60. Smith L.L., and Johnson B.H. Biological activities of oxysterols. Free Radic. Biol. Med. 7 (1989) 285-332
61. Sottero B., Gamba P., Longhi M., Robbesyn F., Abuja P.M., Schaur R.J., Poli G., and Leonarduzzi G. Expression and synthesis of TGFβ1 is induced in macrophages by 9-oxononanoyl cholesterol, a major cholesteryl ester oxidation product. Biofactors 24 (2005) 209-216
62. Suarna C., Dean R.T., May J., and Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1616-1624
63. Sung S.C., Kim K., Lee K.A., Choi K.H., Kim S.M., Son Y.H., Moon Y.S., Eo S.K., and Rhim B.Y. 7-Ketocholesterol upregulates interleukin-6 via mechanisms that are distinct from those of tumor necrosis factor-α, in vascular smooth muscle cells. J. Vasc. Res. 46 (2009) 36-44
64. Vejux A., and Lizard G. Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol. Aspects Med. 30 (2009) 153-170
65. Wilson D., Massaeli H., Pierce G.N., and Zahradka P. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels. Mol. Cell. Biochem. 249 (2003) 141-149
66. Zanetti D., Poli G., Vizio B., Zingaro B., Chiarpotto E., and Biasi F. 4-Hydroxynonenal and transforming growth factor-β1 expression in colon cancer. Mol. Aspects Med. 24 (2003) 273-280